合肥拓锐生物科技有限公司是一家专业的新药开发,新药研发公司

Chinese | English

新药研发首页 > Patents Transfer > Patents Transfer projects
Patents Transfer projects
Triflusal
2012-3-29
 

Triflusal

We provide skill&technology transfer of Triflusal pills / new plant building guidance ;We also provide these pills  if you need finish product;

 

Ⅰ:Name:       Triflusal    

Ⅱ:Formulations: pills/capsule  or bulk  drugs

Ⅲ:Specs:       300mg/pill   ;  or  as  requirement;

Ⅳ:Indications:   Anti-platelet aggregation drugs

Prevention of myocardial infarction, stable or unstable angina, thrombosis by transient ischemic attack or stroke,; to reduce coronary artery bypass graft thrombosis..

Ⅴ:Dosage: 

(1)    Suggest: 600mg/day,  by one or two time;  900mg/day, by two or three time

(2)    Better take it when have meals

(3)    Be careful for those liver and kidney dysfunction

 

Ⅵ:Features:  Through the irreversible inhibition on the platelet cyclooxygenase,so as to reduce thrombus formation; its major metabolite matter HTB (3 - hydroxy - 4 - trifluoromethyl-benzoic acid) is a reversible inhibitor of platelet cyclooxygenase, and its half-life period is so long (approximately 34 hours)

Ⅶ:Areas export : Africa

Middle East

Latin America

South East Asia

Esat Euro

Ⅷ:Production capacity  1000,000 pics /week

合肥网站建设 合肥网络推广 合肥seo优化 合肥网络营销 新药研发 药物研发 新药转让